Hjem › Orofaryngeal kreft
Kliniske studier for Orofaryngeal kreft rekrutterer i USA
52 studier for Orofaryngeal kreft rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Edison, NJ8 studier
- Atlanta, GA8 studier
- Chicago, IL7 studier
- New York City, NY6 studier
- Queens, NY5 studier
- Los Angeles, CA5 studier
- Philadelphia, PA5 studier
- Pittsburgh, PA5 studier
- Milwaukee, WI5 studier
- St. Louis, MO5 studier
- Omaha, NE5 studier
- Kansas City, MO5 studier
- Houston, TX5 studier
- Tampa, FL5 studier
- Rochester, MN4 studier
- Staten Island, NY4 studier
- Greenburgh, NY4 studier
- East Norwalk, CT4 studier
- Ann Arbor, MI4 studier
- Overland Park, KS4 studier
- Kansas City, KS4 studier
- Detroit, MI4 studier
- Naperville, IL4 studier
- Durham, NC4 studier
- Washington, DC4 studier
- Richmond, VA4 studier
- Baltimore, MD4 studier
- New Rochelle, NY3 studier
- Portland, OR3 studier
- West Bend, WI3 studier
- Champaign, IL3 studier
- Oklahoma City, OK3 studier
- Charleston, IL3 studier
- Danville, IL3 studier
- Des Moines, IA3 studier
- Stevens Point, WI3 studier
- North Peoria, IL3 studier
- Bloomington, IL3 studier
- Aurora, IL3 studier
- Jacksonville, FL3 studier
Etter delstat
- Arizona4 studier
- California9 studier
- Colorado4 studier
- District of Columbia3 studier
- Florida12 studier
- Georgia8 studier
- Illinois8 studier
- Iowa5 studier
- Kansas5 studier
- Kentucky3 studier
- Maryland7 studier
- Massachusetts4 studier
- Michigan6 studier
- Minnesota6 studier
- Missouri9 studier
- Nebraska5 studier
- New Hampshire3 studier
- New Jersey8 studier
- New York11 studier
- North Carolina6 studier
- North Dakota3 studier
- Ohio8 studier
- Oklahoma4 studier
- Oregon3 studier
- Pennsylvania10 studier
- South Carolina3 studier
- Tennessee3 studier
- Texas6 studier
- Vermont3 studier
- Virginia4 studier
- Wisconsin6 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05541016Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07195734Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
Rekrutterer
Alder 65 til 99 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06309225BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06305676Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05172245Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05880797Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07441681Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
RekruttererFase 2
Alder 22 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT04900623Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06254911Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06445114Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT04198766The Minimalist Trial-2
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06702033Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jul. 2026 · NCT05388773Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT06662058pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT05799144Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT01365169Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07178301SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT05451004Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 26. jun. 2026 · NCT04151082E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT05686226Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.